We are looking for participants affected by COPD to participate
in a research study to investigate a possible new treatment.
According to the NIH (National Heart, Lung, and Blood Institute), COPD, or chronic obstructive pulmonary disease, is a progressive disease, which means it gets worse over time. With COPD, less air flows in and out of the airways, making it hard to breathe.
This is a Phase 3 research study looking into the effectiveness and
safety of a new inhaler for COPD.
Study participation will last up to 55 weeks, with a total of 12 visits to the medical clinic.
You will be provided with a pressurized metered dose inhaler to use twice a day. You may also be assessed for vital signs, breathing tests, blood draws, ECG, and an X-Ray.
This study will compensate each participant $56.00 for every completed study visit until the end of the study or withdrawal.
Being involved in our clinical trial won’t cost you anything. All trial-related costs above your usual care will be free. And don’t let travel costs put you off – we’re happy to talk about covering any transportation expenses you need to participate in the study.
A placebo is something that looks identical to the treatment that’s being investigated but doesn’t contain any active medication. It helps us ensure that any results we measure in this clinical trial are due to the study medication and not for any other reason.
Yes. Your participation in a study is completely voluntary, which means you may leave a study, at any time, for any reason. If you choose to leave a study early, it will not affect your ability to participate in future research. You just have to tell the study doctor or the study staff as soon as you change your mind. They may ask you to come back for a final visit to check your health.